a month ago
ERAS
AnalystsKelsey GoodwinKelsey Goodwin's Stock Forecasts
AnalystsKelsey Goodwin
Sectors:
Industries:
Analyst Ranking
Top 6%
#288 out of 5263 analysts
Average Return
+65.98%
Win Rate
75%24 out of 32
Risk vs Reward
Poor
Good
Kelsey Goodwin's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Century Therapeutics IncIPSC | +336.04% | $0.56 | $2.42 | 2025-03-20 - 2026-03-20 | Strong Buy |
Erasca IncERAS | +315.67% | $5.17 | $21.49 | 2026-01-06 - 2026-04-24 | Strong Buy |
Revolution Medicines IncRVMD | +270.28% | $36.54 | $135.30 | 2025-08-18 - 2026-04-24 | Strong Buy |
Tango Therapeutics IncTNGX | +270.26% | $6.96 | $25.77 | 2025-08-18 - 2026-04-24 | Strong Buy |
Cg Oncology IncCGON | +168.70% | $25.56 | $68.68 | 2025-08-18 - 2026-04-24 | Strong Buy |
Kelsey Goodwin Analyst Color
Get additional color on Kelsey Goodwin's coverage of popular stocks
2 months ago
RVMD
3 months ago
TNGX
3 months ago
ERAS
3 months ago
CGON
6 months ago
DAWN
6 months ago
NUVL
Kelsey Goodwin's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Relmada Therapeutics IncRLMD | 1 | Strong Buy | $12.00 | +66.44% | Initiates Coverage On | a month ago |
Erasca IncERAS | 3 | Strong Buy | $18.00 | -16.24% | Maintains | a month ago |
Arcellx IncACLX | 3 | Hold | $115.00 | -0.03% | Downgrades | 2 months ago |
Revolution Medicines IncRVMD | 2 | Strong Buy | $120.00 | -11.31% | Maintains | 2 months ago |
Tango Therapeutics IncTNGX | 2 | Strong Buy | $14.00 | -45.67% | Maintains | 3 months ago |
Janux Therapeutics IncJANX | 2 | Strong Buy | $30.00 | +99.87% | Maintains | 3 months ago |
Cg Oncology IncCGON | 2 | Strong Buy | $70.00 | +1.92% | Maintains | 3 months ago |
Black Diamond Therapeutics IncBDTX | 2 | Strong Buy | $8.00 | +169.36% | Maintains | 3 months ago |
Protara Therapeutics IncTARA | 1 | Strong Buy | $24.00 | +367.84% | Initiates Coverage On | 4 months ago |
Oric Pharmaceuticals IncORIC | 1 | Strong Buy | $22.00 | +114.84% | Initiates Coverage On | 4 months ago |
Day One Biopharmaceuticals IncDAWN | 1 | Strong Buy | $26.00 | +20.76% | Maintains | 6 months ago |
Nuvalent IncNUVL | 4 | Strong Buy | $128.00 | +22.49% | Maintains | 6 months ago |
Summit Therapeutics IncSMMT | 1 | Hold | $21.00 | -4.89% | Initiates Coverage On | 8 months ago |
Urogen Pharma LtdURGN | 3 | Strong Buy | $36.00 | +49.32% | Initiates Coverage On | 8 months ago |
Bicara Therapeutics IncBCAX | 1 | Strong Buy | $36.00 | +58.94% | Initiates Coverage On | 8 months ago |
Century Therapeutics IncIPSC | 2 | Strong Buy | $5.00 | N/A | Maintains | a year ago |
Genelux CorpGNLX | 1 | Strong Buy | $8.00 | N/A | Initiates Coverage On | a year ago |
2seventy Bio IncTSVT | 2 | Strong Buy | $26.00 | N/A | Maintains | 3 years ago |
Legend Biotech CorpLEGN | 1 | Hold | N/A | N/A | Initiates Coverage On | 3 years ago |
Iovance Biotherapeutics IncIOVA | 1 | Hold | N/A | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.